Search Results 251-260 of 24188 for In situ
Scientists in the Liver Transplant Research Program at Mayo Clinic conduct basic ... Diagnostic studies for cholangiocarcinoma, such as fluorescent in situ ...
RNA in situ hybridization. Custom optimization of new antibodies. Tissue microarray construction. Digital imaging and analysis. More about research at Mayo ...
... in situ hybridization (FISH) who have received at least one line of therapy ... Other malignancy requiring active therapy. EXCEPTIONS: Non-melanoma skin cancer, ...
Participation eligibility · Synovial sarcoma; · A SMARCB1-null tumor as determined by immunohistochemistry, fluorescent in situ hybridization, or other equivalent ...
... in situ cancer, lobular carcinoma of the breast in situ, cervical cancer in situ, atypical melanocytic hyperplasia or melanoma in situ are eligible ...
- Carcinoma in situ of the cervix, - Carcinoma in situ of the breast, - Incidental histological finding of prostate cancer 10. Participants with clinical ...
This is a phase II trial that will study how well tucatinib (ONT-380) and trastuzumab work in ... in situ, or Stage I uterine cancer). Subjects with known active ...
Drugs used in chemotherapy, such as docetaxel, doxorubicin, cyclophosphamide, paclitaxel, and gemcitabine work in different ways to stop tumor cells from ...
Lobular carcinoma in situ (LCIS) ... This study will recruit breast cancer patients and survivors to take part in an ongoing study of the issues and concerns ...
The purpose of this study is to examine the biology of Serous Tubal In Situ Carcinoma (STIC) lesions by conducting a proteomic and genomic analysis of STIC ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.